A groundbreaking treatment, retatrutide, is generating considerable excitement within the Aussie weight loss community. Designed by Lilly , this dual GIP and GLP-1 receptor appears to provide more substantial benefits than current therapies. Initial scientific studies have shown remarkable decreases in physical fat , raising the for a different met